Sign up for HAMODIA'S
Breaking News Emails*
According to a new report from the Blue Cross Blue Shield Association, whose researchers looked at almost 10 million children in the U.S., the rate of emergency room visits due…
An online pharmacy that bills itself as Canada’s largest was fined $34 million Friday for importing counterfeit cancer drugs and other unapproved pharmaceuticals into the United States, a sentence that…
Pfizer’s fourth-quarter profit soared to $12.27 billion, thanks to a huge tax benefit related to the U.S. tax system overhaul. The biggest U.S. drugmaker on Tuesday reported an $11.34 billion…
New Jersey filed a lawsuit Tuesday against the company that manufactures OxyContin, claiming a “direct link” between the state’s opioid crisis and the firm’s deceptive marketing practices. State Attorney General…
In 23 years, Amazon has transformed itself from a relatively unknown online retailer into a behemoth that has toppled traditional big-box stores by attracting consumers to its speedy home delivery…
Higher spending across the board drove Johnson & Johnson’s third-quarter profit down 12 percent, despite a big sales jump fueled by recent acquisitions, hot new cancer drugs and strong sales…
Teva Pharmaceuticals chose a new CEO on Monday, a Danish executive who was lauded for among other things his “turnaround experience,” Globes reported. After thrashing about for six months in…
Teva Pharmaceutical Industries has fallen to pieces – and now is the time for investors to pick up those pieces, an industry analyst told Globes on Thursday. Teva has taken…
Gilead Sciences will pay $11.9 billion in cash to buy Israeli-founded Kite Pharma and plant a stake in an emerging area of cancer treatments that train a patient’s immune cells…
Mylan’s $465 million settlement of a U.S. case that claimed the drugmaker defrauded taxpayers by misclassifying its allergy-shot EpiPen product as a generic drug was finalized by the Justice Department.…
The news was all bad for Teva Pharm on Sunday after the company lost a third of its value in two trading days following a series of financial setbacks and…
The Knesset Finance Committee has given Teva Pharmaceuticals an ultimatum: Either hold off on 350 planned layoffs to allow for talks with the workers, or face tough scrutiny of the…
Another Israeli firm is joining the billion-dollar club. Biopharmaceutical firm NeuroDerm is to be purchased by Mitsubishi Tanabe Pharma. According to Globes, the Japanese firm will pay cash in the…
U.S. drugmaker Pfizer has denied allegations it over-charged for cancer medicines in South Africa following an investigation launched on Tuesday into three drug companies by the country’s competition watchdog. The…
The U.S. Supreme Court on Monday cut the time it will take for copycat versions of biologic drugs to get to the market in a pivotal ruling about an expensive…